论文部分内容阅读
目的：提高膀胱非移行细胞肿瘤的诊治水平。方法：结合文献对收治的18例膀胱非移行细胞肿瘤的诊断与治疗进行讨论。结果：18例膀胱非移行细胞肿瘤占同期352例膀胱肿瘤的5．1％。其中良性非移行细胞肿瘤3例（16．7％），恶性非移行细胞肿瘤15例（83．3％），后者以鳞癌、腺癌及其与移行细胞癌混合癌为主，占73．3％，且临床分期T3期以上者亦占73．3％。以血尿和膀胱刺激症状为主要临床表现。治疗以膀胱全切除及部分切除为主，其1、3及5年生存率分别为85．7％、66·7％及57．1％。结论：膀胱非移行细胞肿瘤的预后与其临床分期、治疗方式选择有关。
Objective: To improve the diagnosis and treatment of non-metastatic bladder tumor. Methods: 18 cases of bladder non-transitional cell tumor diagnosis and treatment were discussed in combination with the literature. Results: 18 cases of bladder non-transitional cell tumors accounted for 5.1% of 352 cases of bladder tumors in the same period. There were 3 cases (16.7%) of benign non-metastatic cell tumor and 15 (83.3%) malignant non-metastatic cell tumor, the latter being squamous cell carcinoma, adenocarcinoma and mixed cancer of transitional cell carcinoma, accounting for 73 .3%, and clinical stage T3 also accounted for more than 73.3%. Hematuria and bladder irritation as the main clinical manifestations. Treatment of total bladder resection and partial resection, 1,3 and 5-year survival rates were 85.7%, 66.7% and 57.1%. Conclusion: The prognosis of non-metastatic bladder tumor is related to its clinical stage and treatment options.